Replies to post #323478 on NorthWest Biotherapeutics Inc (NWBO)

[rosemountbomber]

Thanks for posting. Both bullish and bearish arguments make some sense although if the bullish case is correct it makes one wonder why the trial was not halted for efficacy two years ago. Surely tgey had plenty of data by then

[alexander77]

The trial didn´t stop because for superior efficacy because of the unexpected high number of patients crossing over from placebo to dcvax-l. And because the primary endpoint was PFS, it was too hard to determine PFS/pseudo PFS. that´s the only reason.
So only the bullish case remains. Do your dd.